Tsugane S, Suzuki Y, Takayasu M, Shibuya M, Sugita K
Department of Neurosurgery, Nagoya University School of Medicine, Japan.
J Auton Nerv Syst. 1994 Sep;49 Suppl:S133-6. doi: 10.1016/0165-1838(94)90101-5.
Vasopressin may regulate the regional cerebral blood flow (rCBF) via two balancing effects: increased flow from the vessels dilated by nitric oxide from the endothelium, and decreased flow from the vessels contracted by direct stimulation of smooth muscle. The effect on the rCBF in anesthetized dogs following the intracisternal or intraarterial administration of vasopressin was investigated by laser flowmetry with the device placed on the dura over the parietal cortex. The intracisternal injection of 1 nmol vasopressin significantly increased the rCBF to 145.3 +/- 27.3% of base line. In contrast, the intravertebral arterial injection of vasopressin had no significant effect on the rCBF. This can be explained by a difference in the affected vasculature; mainly large vessels in the subarachnoid space vs. whole vascular system supplied by the vertebral artery. The intracisternal injection of 10 mumol of NG-monomethyl-L-arginine (L-NMMA) reduced the rCBF; pretreatment with this agent significantly suppressed the elevation in rCBF induced by vasopressin. The intraarterial injection of L-NMMA reduced the rCBF more than its intracisternal administration. It also suppressed the rCBF induced by vasopressin.
血管加压素可能通过两种平衡效应来调节局部脑血流量(rCBF):一种是通过内皮产生的一氧化氮使血管扩张,从而增加血流量;另一种是直接刺激平滑肌使血管收缩,从而减少血流量。通过将激光血流仪放置在顶叶皮质硬脑膜上来研究在麻醉犬中经脑池内或动脉内给予血管加压素后对rCBF的影响。脑池内注射1 nmol血管加压素可使rCBF显著增加至基线的145.3±27.3%。相比之下,经椎动脉内注射血管加压素对rCBF无显著影响。这可以通过受影响的脉管系统的差异来解释:蛛网膜下腔主要是大血管,而椎动脉供应的是整个血管系统。脑池内注射10 μmol的N-甲基-L-精氨酸(L-NMMA)可降低rCBF;用该药物预处理可显著抑制血管加压素诱导的rCBF升高。动脉内注射L-NMMA比脑池内给药更能降低rCBF。它还能抑制血管加压素诱导的rCBF。